Abstract
Background: Based on a common belief among people, narcotic substances and psychoactive drugs may help to reduce blood glucose and lipid profile leading to reduced risk of cardiovascular diseases. This hypothesis has been verified in several studies; however, there is no conclusive agreement on the reducing effects of opium and other opioid derivatives on blood glucose and lipids. In the present review, we collected all related literature to evaluate the effects of opioids and psychoactive drugs abuse in altering blood glucose and lipid profile, and discuss their longterm effects.
Methods: A systematic literature search was performed in January 2021 using “lipid profile”, “glucose”, and “opium” including all their equivalents, main derivatives and similar terms. The data were then extracted and reported qualitatively.
Results: Overall, 46 articles with 37407 participants were included after several step–by-step procedures of article selection. Findings of this study suggested that opioids may reduce blood glucose and low-density lipoproteins, while increasing triglyceride. However, these effects are temporary, and long-term substance abuse exacerbates glucose and lipid-associated diseases such as diabetes and atherosclerosis.
Conclusion: Although there are many confounding factors that may affect the results of the included literature; however, based on the findings of these studies, the long-term beneficial effects of opioids on lipid profile and blood glucose cannot be accepted.
Keywords: Opioids, opium, psychoactive drugs, metabolic status, endocrine, blood glucose.
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Effects of Opioids and Psychoactive Drugs on Blood Lipid and Glucose Indices; A Systematic Review of Population-Based Evidences
Volume: 21 Issue: 12
Author(s): Azam Rezaei and Maryam Rezaei *
Affiliation:
- Medical Toxicology and Drug Abuse Research Center (MTDRC), Birjand University of Medical Sciences, Birjand,Iran
Keywords: Opioids, opium, psychoactive drugs, metabolic status, endocrine, blood glucose.
Abstract: Background: Based on a common belief among people, narcotic substances and psychoactive drugs may help to reduce blood glucose and lipid profile leading to reduced risk of cardiovascular diseases. This hypothesis has been verified in several studies; however, there is no conclusive agreement on the reducing effects of opium and other opioid derivatives on blood glucose and lipids. In the present review, we collected all related literature to evaluate the effects of opioids and psychoactive drugs abuse in altering blood glucose and lipid profile, and discuss their longterm effects.
Methods: A systematic literature search was performed in January 2021 using “lipid profile”, “glucose”, and “opium” including all their equivalents, main derivatives and similar terms. The data were then extracted and reported qualitatively.
Results: Overall, 46 articles with 37407 participants were included after several step–by-step procedures of article selection. Findings of this study suggested that opioids may reduce blood glucose and low-density lipoproteins, while increasing triglyceride. However, these effects are temporary, and long-term substance abuse exacerbates glucose and lipid-associated diseases such as diabetes and atherosclerosis.
Conclusion: Although there are many confounding factors that may affect the results of the included literature; however, based on the findings of these studies, the long-term beneficial effects of opioids on lipid profile and blood glucose cannot be accepted.
Export Options
About this article
Cite this article as:
Rezaei Azam and Rezaei Maryam *, Effects of Opioids and Psychoactive Drugs on Blood Lipid and Glucose Indices; A Systematic Review of Population-Based Evidences, Endocrine, Metabolic & Immune Disorders - Drug Targets 2021; 21 (12) . https://dx.doi.org/10.2174/1871530321666210809155928
DOI https://dx.doi.org/10.2174/1871530321666210809155928 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
Call for Papers in Thematic Issues
Advances in Therapeutic Strategies: Bridging Endocrine, Metabolic, Cancer and Immune Disorders for Precision Medicine.
The intricate interplay between endocrine, metabolic, and immunological disorders, addressing the challenges posed by their overlapping pathophysiology. With a focus on diseases such as diabetes, obesity, autoimmune thyroid conditions, and systemic inflammatory disorders, it highlights the transformative potential of precision medicine. Advances in genomics, transcriptomics, proteomics, and metabolomics are uncovering ...read more
Advancing Therapies for Bone and Joint Diseases: Insights from Natural Products and Herbal Medicines
The aging global population is experiencing an increased risk of bone and joint health issues, notably osteoporosis and osteoarthritis, affecting over half of individuals over 60. Plant-based natural products and herbal medicines are gaining recognition as alternative therapies for these conditions, with secondary metabolites, including flavonoids, coumarins, and others, playing ...read more
Association between Diabetes Mellitus and natural product complementary applications: State of the arts
Diabetes Mellitus (DM) represents a significant global health challenge, characterized by chronic hyperglycemia resulting from defects in insulin secretion, insulin action, or both. The increasing prevalence of DM, alongside its associated complications, has prompted researchers and healthcare professionals to explore a variety of management strategies beyond conventional pharmacotherapy. Among these ...read more
Chronic inflammation and Disorders/Cancers
Chronic inflammation is fundamental cause of variety of disorders. Many lifestyle-related diseases including metabolic syndrome, obesity, impairment of immune responses, sepsis, mental illness, and other disorders are caused by chronic inflammation. Prevention of chronic inflammation is related to antiaging effects of our body. Proinflammatory cytokines such as TNF-α is associated ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Development of New N- and S-substituted-imidazolidin-4-one Analogues with Potent
Anti-breast Cancer Activity: <i>In vitro</i> Molecular Docking Assessment
Current Organic Chemistry Discovery of Novel Genes Mediating Glucose and Lipid Metabolisms
Current Protein & Peptide Science Broadening Our View of Protective Antibody Responses Against HIV
Current HIV Research Cigarette Smoking and Angiogenesis: What is the Role of Endothelial Progenitor Cells?
Current Angiogenesis (Discontinued) Can Non-invasive Biomarkers Lead to an Earlier Diagnosis of Alzheimer’s Disease?
Current Alzheimer Research Disorders of Mineral Metabolism in the Newborn
Current Pediatric Reviews Recent Update on the Alzheimer's Disease Progression, Diagnosis and Treatment Approaches
Current Drug Targets Genetic and Non-Genetic Determinants of the Pharmacological Activity of Statins
Current Drug Metabolism Diabetic Retinopathy Leading to Blindness- A Review
Current Diabetes Reviews Docking, Synthesis and Anti-Diabetic Activity of Novel Sulfonylhydrazone Derivatives Designed as PPAR-Gamma Agonists
Current Topics in Medicinal Chemistry Microbiome in Critical Care: An Unconventional and Unknown Ally
Current Medicinal Chemistry Anti-Seizure Medications and Estradiol for Neuroprotection in Epilepsy: The 2013 Update
Recent Patents on CNS Drug Discovery (Discontinued) Implication of CD154/CD40 Interaction in Healthy and Autoimmune Responses
Current Immunology Reviews (Discontinued) Proteins of the Esterase Family: Patents for Some Proteins in Search of Metabolic Functions
Recent Patents on Biomarkers Effects of Metformin-Single Therapy on the Level of Inflammatory Markers in Serum of Non-Obese T2DM Patients with NAFLD
Endocrine, Metabolic & Immune Disorders - Drug Targets Editorial [“Current Aging Science”: An Important Platform for Reporting Advances in Aging-related Research]
Current Aging Science Drugs Against Echinococcosis
Drug Design Reviews - Online (Discontinued) Vitamin D and Cardiovascular Disease: A Novel Agent for Reducing Cardiovascular Risk?
Current Vascular Pharmacology Activation of Integrin β1 Mediates the Increased Malignant Potential of Ovarian Cancer Cells Exerted by Inflammatory Cytokines
Anti-Cancer Agents in Medicinal Chemistry Nanoscale Membrane Organization and Receptor Signaling in T- Lymphocytes
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)